Lactic Acid

Lactic Acid

SCHEMBL370698

CC(O)C(=O)O.CCOC(=O)C(C)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.55
ALDH1A1 P00352 3/20 0.43
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
PIN1 Q13526 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
TRPA1 O75762 1/20 0.37
MMP8 P22894 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL28409875 0.98 TP53 (0.52) TP53ALDH1A1LMNAHSD17B10ALOX15
Lactic Acid SCHEMBL28582874 0.95 TP53 (0.50) TP53ALDH1A1LMNAHSD17B10ALOX15
Lactic Acid SCHEMBL4061613 0.95 TP53 (0.50) TP53ALDH1A1LMNAHSD17B10ALOX15
Hydrogen Peroxide SCHEMBL5367632 0.95 ALDH1A1 (0.48) TP53ALDH1A1LMNAHSD17B10ALOX15
Lactic Acid SCHEMBL5697793 0.93 TP53 (0.48) TP53ALDH1A1LMNAHSD17B10ALOX15
Bicarbonate SCHEMBL28391088 0.92 ALDH1A1 (0.46) TP53ALDH1A1LMNAHSD17B10ALOX15
SCHEMBL22598 0.92
SCHEMBL29615225 0.92
SCHEMBL471892 0.92 ALDH1A1 (0.50) TP53ALDH1A1LMNAHSD17B10ALOX15
SCHEMBL344175 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240141502-A1 METAL SURFACE TREATMENT AGENT HITACHI, LTD. (JP) 2024-05-02 US disclosed
CN-219804615-U Catalytic reactor for preparing ethyl lactate from lactic acid 天津中福环保科技股份有限公司 2023-10-10 CN disclosed
CN-219804615-U Catalytic reactor for preparing ethyl lactate from lactic acid 天津中福环保科技股份有限公司 2023-10-10 CN disclosed
US-20210253814-A1 ORGANOSILANE COATING COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2021-08-19 US disclosed
EP-3793750-A1 ORGANOSILANE COATING COMPOSITIONS NBD Nanotechnologies, Inc. (US) 2021-03-24 EP disclosed
US-20200208012-A1 ADHESION PROMOTERS AND THEIR USE HENKEL AG & CO. KGAA (DE) 2020-07-02 US disclosed
EP-3672798-A1 ADHESION PROMOTERS AND THEIR USE NBD Nanotechnologies, Inc. (US) 2020-07-01 EP disclosed
WO-2019040922-A1 ADHESION PROMOTERS AND THEIR USE NBD NANOTECHNOLOGIES, INC. (US) 2019-02-28 WO disclosed
US-20120016072-A1 HARDENER FOR SILICONE RUBBER MATERIALS NITRO-CHEME ASCHAU GmbH (DE) 2012-01-19 US disclosed
US-7968276-B2 Positive resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2011-06-28 US disclosed
US-20090181325-A1 POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-07-16 US disclosed
EP-0722469-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF LACTIDE AND LACTIDE POLYMERS CARGILL, INCORPORATED (US) 1996-07-24 EP disclosed
WO-1995009879-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF LACTIDE AND LACTIDE POLYMERS CARGILL, INCORPORATED (US) 1995-04-13 WO disclosed
EP-0623153-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF LACTIDE AND LACTIDE POLYMERS CARGILL, INCORPORATED (US) 1994-11-09 EP disclosed
WO-1993015127-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF LACTIDE AND LACTIDE POLYMERS CARGILL, INCORPORATED (US) 1993-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016072-A1 HARDENER FOR SILICONE RUBBER MATERIALS HACD2, HACD3, ITGA2 TP53 3523/4885ALDH1A1 559/4885LMNA 2007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.